Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel

The CYP2C19 LOF alleles may increase the recurrent risk of ischemic events. The polymorphisms of CYP2C19 may be predictors of poor functional outcome of patients without stent, and the effect may be weakened by time.